Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible

Pediatric Blood and Cancer

Volumn 51, Issue 5, 2008, Pages 629-633

  Lucchini, Giovanna ^a   Grioni, Daniele ^a   Colombini, Antonella ^a   Contri, Margherita ^a   De Grandi, Carlo ^a   Rovelli, Attilio ^a   Conter, Valentino ^a   Masera, Giuseppe ^a   Jankovic, Momcilo ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Acute symptomatic seizures; Childhood; Encephalopathy; Epilepsy; Leukemia; Posterior reversible leukoencephalopathy

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; PHENOBARBITAL; VALPROIC ACID; VINCRISTINE;

ADOLESCENT; ARTICLE; BRAIN DISEASE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ELECTROENCEPHALOGRAM; ENCEPHALOPATHY SYNDROME; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKOENCEPHALOPATHY; MALE; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY; PRIORITY JOURNAL; REMISSION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; DIFFUSION MAGNETIC RESONANCE IMAGING; ELECTROENCEPHALOGRAPHY; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; SYNDROME;

EID: 52249118305     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21688     Document Type: Article

References (21)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Pavlakis SG, Frank Y, Kalina P, et al. Occipital parietal encephalopathy: A new name for an old syndrome. Pediatr Neurol 1997;16:145-148.
3. Misawa A, Takeuchi Y, Hibi S, et al. FK-506 induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. Bone Marrow Transpl 2000;25:331-334.
4. Higman MA, Port JD, Beaucham NJ, et al. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transpl 2000;26:797-800.
5. Trullemans F, Grgnard F, Van Camp B, et al. Clinical findings and magnetic resonance imaging in severe cyclosporine related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol 2001;67:94-99.
6. Antunes NL, Small TN, George D, et al. Posterior Leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999;20:241-243.
7. Wood P, Helton K, McDaniel H, et al. Encephalopathy in pediatric patients after allogeneic bone hematopoietic stem cell transplantation is associated with a poor prognosis. Bone Marrow Transpl 2004;33:1151-1157.
8. Yukiro MA, Fisher PG, Barnes PD, et al. A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation. Pediatr Blood Cancer 2007;48:213-217.
9. Brannon ME, Laningham FH, Sandlund JT, et al. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 2007;48:152-159.
10. Pession A, Rondelli R, Basso G, et al. Treatment and long term results in children with acute myeloid leukemia treated according to the AIEOPAML protocols. Leukemia 2005;19:2043-2053.
11. Testi AM, Biondi A, Lo Coco F, et al. GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood 2005;15:447-453.
12. Arico' M, Conter V, Valsecchi MG, et al. Treatment reduction in highly selected standard risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study. Haematologica 2005;90:1186-1191.
13. Rovelli A, Corti P, Beretta C, et al. Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia. J Pediatr Gastroenterol Nutr 2007;45:596-599.
14. Bartynski WS. Posterior reversible encephalopathy syndrome, Part 2: Controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29:1036-1042.
15. Seo SW, Lee BI, Lee JD, et al. Thyrotoxic autoimmune encephalopathy: A repeat positron emission tomography study. J Neurol Neurosurg Psychiatry 2003;74:504-506.
16. Angeleri F, Majkowski J, Cacchio G, et al. Post traumatic epilepsy risk factors: One-year prospective study after head injury. Epilepsia 1999;40:1222-1230.
17. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497-502.
18. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of post traumatic seizures: A randomized trial. J Neurosurg 1999;91:593-600.
19. Cole AJ, Dichter M. Neuroprotection and antiepileptogenesis: Overview, definitions and context. Neurology 2002;59:S1-S2.
20. Acharya MM, Hattiangady B, Shetty AK. Progress on neuroprotective strategies for preventing epilepsy. Progr Neurobiol 2008;84:363-404.
21. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 2002;50:105-123.